Cite
HARVARD Citation
Tétu, P. et al. (2018). Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma. European journal of cancer. pp. 147-149. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tétu, P. et al. (2018). Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma. European journal of cancer. pp. 147-149. [Online].